Design, Synthesis, and Anticancer Activity of Amide Derivatives of Structurally Modified Combretastatin-A4

A new series of amide derivatives of structurally modified combretastatin-A4 10a-10j are synthesized, and their structures are confirmed by H-1 and C-13 NMR, and mass spectral data. The products are tested for their anticancer activity towards human cancer cell lines, MCF-7 (breast), A-549 (lung), Colo-205 (colon), and A-2780 (ovarian). The compounds 10b, 10c, and 10d demonstrate the most promising activity.